The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 310 participants.

Also called NCT04733443

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 310 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04733443
Other papers using this trial's data
  • Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2024-07-01 DOI, PubMed 38742581, PMC11200665 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04733443. Randomized; no masking; primary purpose treatment. Start 2020-12-17 (actual); primary completion 2023-01-18 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Safety and Efficacy of Biolimus in the Treatment of Patients With in Stent Restenosis
Intervention (Device)
Biolimus
Intervention (Device)
SeQuent® Please Neo
Lead sponsor
JW Medical Systems Ltd (class: industry)

Record details

Record id
cardio:ct-nct04733443
Content hash
ab755d39653d6620c78e77c11ae8fa278545b419952371498db3f0eb06b266e3